ASML Deep Coverage Review — Analysis as of August 3, 2026
ASML’s Q2 revenue rose 11% and new-system shipments rose 28%, but missing bookings confirmation and weak price structure keep the cycle unresolved.
CAMS Research Desk
MS Research Note — Results Lead the Tape
Morgan Stanley’s record quarter strengthens the operating case, while sector lag and an unresolved Wealth Management question raise the proof bar.
MS Deep Coverage Review — Analysis as of August 3, 2026
Morgan Stanley’s record returns strengthen the franchise case, but relative weakness and an unresolved control question keep the valuation contested.
Desk Note — Manufacturing Reaccelerates, Rates Reprice · Aug 03
July manufacturing activity accelerated sharply, strengthening cyclical rotation evidence while keeping rate sensitivity in focus.
UNH Research Note — Repair Needs More Proof
UnitedHealth improved Medicare cost evidence in July, but commercial pressure and a broader federal inquiry keep the repair incomplete.
UNH Deep Coverage Review — Analysis as of August 3, 2026
UnitedHealth shows measurable Medicare cost improvement, while commercial pressure and a broader federal inquiry keep the repair incomplete.
Market Structure: Leadership Converges Before Earnings — August 3, 2026
Healthcare, financials, and energy lead by similar margins, but this week’s company reports will test three very different market trends.
QQQ Research Note — Long Trend, Narrow Leadership
QQQ held its long-term trend, but narrow breadth, technology weakness and rising yields leave the August evidence window unusually important.
QQQ Deep Coverage Review — Analysis as of August 3, 2026
QQQ’s long-term trend held, but narrow breadth, technology weakness and a 4.74% ten-year yield raise the burden of proof through August.
JPM Research Note — Record Quarter, Higher Bar
JPMorgan’s record quarter supports the operating case, but rates, credit and a premium valuation leave the next evidence unusually important.